Spots Global Cancer Trial Database for Mix Vaccine for Metastatic Sarcoma Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Mix Vaccine for Metastatic Sarcoma Patients
Official Title: Safety and Efficacy Study of Mix Vaccine in Sarcoma Patient
Study ID: NCT03357315
Interventions
Study Description
Brief Summary: The aim of this study is the safety and efficacy of mix vaccine to small metastases of sarcoma.
Detailed Description: By enrolling patients with small metastases of sarcoma adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of mix vaccine. The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).
Keywords
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Fuda cancer institute of Fuda cancer hospital, Guangzhou, Guangdong, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
